Skip to main content
Mijn bibliotheek
Shop
Nieuws Boeken Tijdschriften E-learning Web-tv Video Audio
Tips voor Mijn BSL
UITGEBREID ZOEKEN
Inloggen
Top
Quality of Life Research
Gepubliceerd in: Quality of Life Research 3/2021

15-09-2020

Comparing EQ-5D-3L and EQ-5D-5L performance in common cancers: suggestions for instrument choosing

Auteurs: Juan Zhu, Xin-Xin Yan, Cheng-Cheng Liu, Hong Wang, Le Wang, Su-Mei Cao, Xian-Zhen Liao, Yun-Feng Xi, Yong Ji, Lin Lei, Hai-Fan Xiao, Hai-Jing Guan, Wen-Qiang Wei, Min Dai, Wanqing Chen, Ju-Fang Shi

Gepubliceerd in: Quality of Life Research | Uitgave 3/2021

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail
    Link delen
publish
Publiceer nu

Abstract

Purpose

To compare the performance of three-level EuroQol five-dimensions (EQ-5D-3L) and five-level EuroQol five-dimensions (EQ-5D-5L) among common cancer patients in urban China.

Methods

A hospital-based cross-sectional survey was conducted in three provinces from 2016 to 2018 in urban China. Patients with breast cancer, colorectal cancer, or lung cancer were recruited to complete the EQ-5D-3L and EQ-5D-5L questionnaires. Response distribution, discriminatory power (indicator: Shannon index [H′] and Shannon evenness index [J′]), ceiling effect (the proportion of full health state), convergent validity, and health-related quality of life (HRQoL) were compared between the two instruments.

Results

A total of 1802 cancer patients (breast cancer: 601, colorectal cancer: 601, lung cancer: 600) were included, with the mean age of 55.6 years. The average inconsistency rate was 4.4%. Compared with EQ-5D-3L (average: H′ = 1.100, J′ = 0.696), an improved discriminatory power was observed in EQ-5D-5L (H′ = 1.473, J′ = 0.932), especially contributing to anxiety/depression dimensions. The ceiling effect was diminished in EQ-5D-5L (26.5%) in comparison with EQ-5D-3L (34.5%) (p < 0.001), mainly reflected in the pain/discomfort and anxiety/depression dimensions. The overall utility score was 0.790 (95% CI 0.778–0.801) for EQ-5D-3L and 0.803 (0.790–0.816) for EQ-5D-5L (p < 0.001). A similar pattern was also observed in the detailed cancer-specific analysis.

Conclusions

With greater discriminatory power, convergent validity and lower ceiling, EQ-5D-5L may be preferable to EQ-5D-3L for the assessment of HRQoL among cancer patients. However, higher utility scores derived form EQ-5D-5L may also lead to lower QALY gains than those of 3L potentially in cost-utility studies and underestimation in the burden of disease.
vorige artikel Population norms of health-related quality of life in Moscow, Russia: the EQ-5D-5L-based survey
volgende artikel A head-to-head comparison of measurement properties of the EQ-5D-3L and EQ-5D-5L in acute myeloid leukemia patients
Bijlagen
Alleen toegankelijk voor geautoriseerde gebruikers
Literatuur
1.
Fitzmaurice, C., Abate, D., Abbasi, N., Abbastabar, H., Abd-Allah, F., Abdel-Rahman, O., et al. (2019). Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: A systematic analysis for the Global Burden of Disease Study. JAMA Oncology, 5, 1749–1768.PubMedPubMedCentral
2.
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A.(2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 68, 394–424.
3.
Zheng, R. S., Sun, K. X., Zhang, S. W., Zeng, H. M., Zou, X. N., et al. (2019). Report of cancer epidemiology in China, 2015. Chinese Journal of Oncology., 41, 19–28.PubMed
4.
Lloyd, A., & Pickard, A. S. (2019). The EQ-5D and the EuroQol Group. Value in Health, 22, 21–22.PubMed
5.
Brooks, R., Rabin, R., & De Charro, F. (2003). The measurement and valuation of health status using EQ-5D: A European perspective. Dordrecht: Springer.
6.
7.
The EuroQol Group. (1990). EuroQol—a new facility for the measurement of health-related quality of life. Health Policy, 16, 199–208.
8.
Janssen, B., Szende, A., & Ramos-Goni, J. M. (2014). Self-reported population health: An international perspective based on EQ-5D. Dordrecht: Springer.
9.
Rabin, R., Gudex, C., Selai, C., & Herdman, M. (2014). From translation to version management: A history and review of methods for the cultural adaptation of the EuroQol five-dimensional questionnaire. Value in Health, 17, 70–76.PubMed
10.
Kopec, J. A., & Willison, K. D. (2003). A comparative review of four preference-weighted measures of health-related quality of life. Journal of Clinical Epidemiology, 56, 317–325.PubMed
11.
Brazier, J., Deverill, M., & Green, C. (1999). A review of the use of health status measures in economic evaluation. Journal of Health Services Research & Policy, 4, 174–184.
12.
Sakthong, P., Sonsa-Ardjit, N., Sukarnjanaset, P., & Munpan, W. (2015). Psychometric properties of the EQ-5D-5L in Thai patients with chronic diseases. Quality of Life Research, 24, 3015–3022.PubMed
13.
Janssen, M. F., Pickard, A. S., Golicki, D., Gudex, C., Niewada, M., Scalone, L., et al. (2013). Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: A multi-country study. Quality of Life Research, 22, 1717–1727.PubMed
14.
Golicki, D., Niewada, M., Karlińska, A., Buczek, J., Kobayashi, A., Janssen, M. F., et al. (2015). Comparing responsiveness of the EQ-5D-5L, EQ-5D-3L and EQ VAS in stroke patients. Quality of Life Research, 24, 1555–1563.PubMed
15.
Pattanaphesaj, J., & Thavorncharoensap, M. (2015). Measurement properties of the EQ-5D-5L compared to EQ-5D-3L in the Thai diabetes patients. Health and Quality of Life Outcomes, 13, 14.PubMedPubMedCentral
16.
Tran, B. X., Ohinmaa, A., & Nguyen, L. T. (2012). Quality of life profile and psychometric properties of the EQ-5D-5L in HIV/AIDS patients. Health and Quality of Life Outcomes, 10, 132.PubMedPubMedCentral
17.
Yfantopoulos, J., Chantzaras, A., & Kontodimas, S. (2017). Assessment of the psychometric properties of the EQ-5D-3L and EQ-5D-5L instruments in psoriasis. Archives of Dermatological Research, 309, 1–14.
18.
Jia, Y. X., Cui, F. Q., Li, L., Zhang, D. L., Zhang, G. M., Wang, F. Z., et al. (2014). Comparison between the EQ-5D-5L and the EQ-5D-3L in patients with hepatitis B. Quality of Life Research, 23, 2355–2363.PubMed
19.
Pan, C. W., Sun, H. P., Wang, X., Ma, Q. H., Xu, Y., Luo, N., et al. (2015). The EQ-5D-5L index score is more discriminative than the EQ-5D-3L index score in diabetes patients. Quality of Life Research, 24, 1767–1774.PubMed
20.
Lorgelly, P., CubiMolla, P., Pennington, M. W., & Norman, R. (2018). Comparing the EQ-5D-3L and EQ-5D-5L in a cohort of cancer patients. Value in Health, 21, S226.
21.
Kim, S. H., Kim, H. J., Lee, S., & Jo, M. W. (2012). Comparing the psychometric properties of the EQ-5D-3L and EQ-5D-5L in cancer patients in Korea. Quality of Life Research, 21, 1065–1073.PubMed
22.
Pickard, A. S., De Leon, M. C. D., Kohlmann, T., Cella, D., & Rosenbloom, S. (2007). Psychometric comparison of the standard EQ-5D to a 5 level version in cancer patients. Medical Care, 45, 259–263.PubMed
23.
Zhou, T., Guan, H. J., Ma, A., & Liu, G. G. (2016). Comparison between the EQ-5D-5L and EQ-5D-3L for general population in China. Value in Health, 19, A829.
24.
Su, M. Z., Hua, X. X., Wang, J. L., Yao, N. L., Zhao, D., Liu, W. D., et al. (2019). Health-related quality of life among cancer survivors in rural China. Quality of Life Research, 28, 695–702.PubMed
25.
Liu, L., Li, S. P., Wang, M., & Chen, G. (2017). Comparison of EQ-5D-5L health state utilities using four country-specific tariffs on a breast cancer patient sample in mainland China. Patient Preference and Adherence, 11, 1049–1056.PubMedPubMedCentral
26.
Huang, W. D., Yang, J. J., Liu, Y., Liu, C. J., Zhang, X., Fu, W. Q., et al. (2018). Assessing health-related quality of life of patients with colorectal cancer using EQ-5D-5L: A cross-sectional study in Heilongjiang of China. British Medical Journal Open, 12, e022711.
27.
Lee, C. F., Luo, N., Ng, R., Wong, N. S., Yap, Y. S., Lo, S. K., et al. (2013). Comparison of the measurement properties between a short and generic instrument, the 5-level EuroQoL Group’s 5-dimension (EQ-5D-5L) questionnaire, and a longer and disease-specific instrument, the Functional Assessment of Cancer Therapy-Breast (FACT-B), in Asian breast cancer patients. Quality of Life Research, 22(7), 1745–1751.PubMed
28.
Janssen, M. F., Bonsel, G. J., & Luo, N. (2018). Is EQ-5D-5L better than EQ-5D-3L? A head-to-head comparison of descriptive systems and value sets from seven countries. Pharmacoeconomics, 36, 675–697.PubMedPubMedCentral
29.
Janssen, M. F., Birnie, E., Haagsma, J. A., & Bonsel, G. J. (2008). Comparing the standard EQ-5D three-level system with a five-level version. Value in Health, 11, 275–284.PubMed
30.
Nunnally, J. C. (1978). Psychometric theory. New York: McGraw-Hill.
31.
Liu, G. G., Wu, H. Y., Li, M. H., Gao, C., & Luo, N. (2014). Chinese time trade-off values for EQ-5D health states. Value in Health, 17, 597–604.PubMed
32.
Luo, N., Liu, G. G., Li, M. H., Guan, H. J., Jin, X. J., & Randhendriksen, K. (2017). Estimating an EQ-5D-5L value set for China. Value in Health, 20, 662–669.PubMed
33.
Shannon, C. E. (1948). A mathematical theory of communication. Bell Labs Technical Journal, 27, 379–423.
34.
Dahl, F. A., & Østerås, N. (2010). Quantifying information content in survey data by entropy. Entropy, 12, 161–163.
35.
Pickard, A. S., Kohlmann, T., Janssen, M. F., Bonsel, G., Rosenbloom, S., Cella, D., et al. (2007). Evaluating equivalency between response systems: Application of the Rasch model to a 3-level and 5-level EQ-5D. Medical Care, 45, 812–819.PubMed
36.
Janssen, M. F., Birnie, E., & Bonsel, G. J. (2007). Evaluating the discriminatory power of EQ-5D, HUI2 and HUI3 in a US general population survey using Shannon’s indices. Quality of Life Research, 16, 895–904.PubMedCentral
37.
Polinder, S., Haagsma, J. A., Bonsel, G., Essinkbot, M. L., Toet, H., & van Beeck, E. F. (2010). The measurement of long-term health-related quality of life after injury: Comparison of EQ-5D and the health utilities index. Injury Prevention, 16, 147–153.PubMed
38.
Kang, E. J., & Ko, S. K. (2009). A catalogue of EQ-5D utility weights for chronic diseases among noninstitutionalized community residents in Korea. Value in Health, 12, S114–117.PubMed
39.
Scalone, L., Ciampichini, R., Fagiuoli, S., Gardini, I., Fusco, F., Gaeta, L., et al. (2012). Comparing the performance of the standard EQ-5D 3L with the new version EQ-5D 5L in patients with chronic hepatic diseases. Quality of Life Research, 22, 1707–1716.PubMed
40.
Kim, T. H., Jo, M. W., Lee, S. I., Kim, S. H., & Chung, M. S. (2013). Psychometric properties of the EQ-5D-5L in the general population of South Korea. Quality of Life Research, 22, 2245–2253.PubMed
41.
Martipastor, M., Pont, A., Avila, M., Garin, O., Vilagut, G., Forero, C. G., et al. (2018). Head-to-head comparison between the EQ-5D-5L and the EQ-5D-3L in general population health surveys. Population Health Metrics, 16, 14.
42.
Yfantopoulos, J. N., & Chantzaras, A. E. (2017). Validation and comparison of the psychometric properties of the EQ-5D-3L and EQ-5D-5L instruments in Greece. The European Journal of Health Economics, 18, 519–531.PubMed
43.
44.
Kim, G. E., Seidler, E., & Kimball, A. B. (2014). The relative impact of psoriasis and obesity on socioeconomic and medical outcomes in psoriasis patients. Journal of the European Academy of Dermatology and Venereology, 28, 216–221.PubMed
45.
Jin, X. J., Liu, G. G., Luo, N., Li, H. C., Guan, H. J., & Xie, F. (2016). Is bad living better than good death? Impact of demographic and cultural factors on health state preference. Quality of Life Research, 25(4), 979e86.
46.
Hang, H. Y., Yang, J., Shi, J. F., Zheng, Z. X., Gu, X. Y., Liang, H., et al. (2017). Quality of life in patients with colorectal cancer in mainland China: A systematic review study. Chinese Journal of Prevention & Control of Chronic Diseases, 25, 629–635.
47.
Wang, L., Shi, J. F., Zhu, J., Huang, H. Y., Bai, Y. N., Liu, G. X., et al. (2018). Health-related quality of life and utility scores of patients with breast neoplasms in China: A multicenter cross-sectional survey. Breast, 39, 53–62.PubMed
48.
49.
van den Bergh, K. A., Essinkbot, M. L., Borsboom, G. J., Scholten, E. T., Prokop, M., de Koninget, H. J., et al. (2010). Short-term health-related quality of life consequences in a lung cancer CT screening trial (NELSON). British Journal of Cancer, 102, 27–34.PubMed
50.
Wilson, T. R., Alexander, D. J., & Kind, P. (2006). Measurement of health-related quality of life in the early follow-up of colon and rectal cancer. Diseases of the Colon & Rectum, 49, 1692–1702.
51.
Alava, M. H., Wailoo, A., Grimm, S., Pudney, S., Gomes, M., Sadique, Z., et al. (2018). EQ-5D-5L versus EQ-5D-3L: The impact on cost-effectiveness in the United Kingdom. Value in Health, 21, 49–56.
52.
Zhuo, L., Xu, L., Ye, J. T., Sun, S., Zhang, Y. G., Burstrom, K., et al. (2018). Time trade-off value set for EQ-5D-3L based on a nationally representative Chinese population survey. Value in Health, 21, 1330–1337.PubMed
53.
Zhu, J., Wang, L., Huang, H. Y., Bai, F. Z., Li, J., Fang, Y., et al. (2019). Short-term impact of breast cancer screening intervention on health-related quality of life in China: A multicenter cross-sectional survey. Psycho-Oncology, 28, 1836–1844.PubMed
Metagegevens
Titel
Comparing EQ-5D-3L and EQ-5D-5L performance in common cancers: suggestions for instrument choosing
Auteurs
Juan Zhu
Xin-Xin Yan
Cheng-Cheng Liu
Hong Wang
Le Wang
Su-Mei Cao
Xian-Zhen Liao
Yun-Feng Xi
Yong Ji
Lin Lei
Hai-Fan Xiao
Hai-Jing Guan
Wen-Qiang Wei
Min Dai
Wanqing Chen
Ju-Fang Shi
Publicatiedatum
15-09-2020
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 3/2021
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-020-02636-w

Andere artikelen Uitgave 3/2021

Quality of Life Research 3/2021 Naar de uitgave

OriginalPaper

Validity of the EQ-5D-5L questionnaire among the general population of Poland

OriginalPaper

Population norms of health-related quality of life in Moscow, Russia: the EQ-5D-5L-based survey

OriginalPaper

Obtaining EQ-5D-5L utilities from the disease specific quality of life Alzheimer’s disease scale: development and results from a mapping study

Review

Quality of life of adolescent idiopathic scoliosis patients under brace treatment: a brief communication of literature review

OriginalPaper

Improving health-related quality of life and adherence to health-promoting behaviors among coronary artery bypass graft patients: a non-randomized controlled trial study

OriginalPaper

Smart wearable devices as a psychological intervention for healthy lifestyle and quality of life: a randomized controlled trial